Inventor
NISWENDER COLLEEN M
US20 patents
⚠️ This page may combine multiple inventors who share the name “NISWENDER COLLEEN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CONN P JEFFREY
11 patentsUS9180192B2Nov 10, 2015
mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY12 citations84
US8916584B2Dec 23, 2014
Benzisoxazoles and azabenzisoxazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY15 citations84
US8759377B2Jun 24, 2014
Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY15 citations84
US8658650B2Feb 25, 2014
Substituted 1,1,3,1-tetraoxidobenzo[D][1,3,2]dithiazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY15 citations84
US9192603B2Nov 24, 2015
Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY12 citations83
US9163015B2Oct 20, 2015
Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY12 citations83
US9108963B2Aug 18, 2015
Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY12 citations83
US8912336B2Dec 16, 2014
Aryl and heteroaryl sulfones as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY12 citations83
US8779157B2Jul 15, 2014
MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CONN P JEFFREY12 citations82
US8697691B2Apr 15, 2014
Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective M1 agonists and methods of making and using same
CONN P JEFFREY2 citations60
US8853392B2Oct 7, 2014
Benzamide mGluR5 positive allosteric modulators and methods of making and using same
CONN P JEFFREY1 citations51
UNIV VANDERBILT
9 patentsUS8034806B2Oct 11, 2011
Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
UNIV VANDERBILT7 citations83
US10508105B2Dec 17, 2019
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT5 citations81
US9980945B2May 29, 2018
Benzoisoxazole-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT8 citations81
US10526323B2Jan 7, 2020
Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT2 citations69
US10227343B2Mar 12, 2019
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT3 citations68
US10221172B2Mar 5, 2019
Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT1 citations62
US12291521B2May 6, 2025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT0 citations60
US11427573B2Aug 30, 2022
Indazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT0 citations60
US11319304B2May 3, 2022
Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
UNIV VANDERBILT0 citations49